Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/14/08 | 8-K | Current report filing |
|
189 | |
| 07/08/08 | 8-K | Current report filing |
|
5 | |
| 07/03/08 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/03/08 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
7 | |
| 07/02/08 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/01/08 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
81 | |
| 06/20/08 | DEF 14C | Definitive information statements |
|
14 | |
| 06/18/08 | PRER14C | Preliminary revised information statements |
|
12 | |
| 06/10/08 | 2-E/A | Report of sales of securities pursuant to Rule 609 under Regulation E. |
|
1 | |
| 06/03/08 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
